Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in Austria

By Brown M.C.J.   Nimmerrichter A.A.   Guest J.F.  

European Psychiatry, Vol. 14, Iss. 4, 1999-07 ,pp. : 230-244

Elsevier

Access to resources Recommend Favorite

Use of Valdoxan (Agomelatin) in the Combined Treatment of Moderate and Severe Nonpsychotic Depression

By Medvedev V.  

Neuroscience and Behavioral Physiology, Vol. 43, Iss. 7, 2013-09 ,pp. : 878-882

Springer Publishing Company

Access to resources Recommend Favorite

Bodily symptoms in moderate and severe depression

By Nyboe Jacobsen Lene   Smith Lassen Irene   Friis Preben   Videbech Poul   Wentzer Licht Rasmus  

Nordic Journal of Psychiatry, Vol. 60, Iss. 4, 2006-08 ,pp. : 294-298

Informa Healthcare

Access to resources Recommend Favorite

Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS)

By Muller M.J.   Himmerich H.   Kienzle B.   Szegedi A.  

Journal of Affective Disorders, Vol. 77, Iss. 3, 2003-12 ,pp. : 255-260

Elsevier

Access to resources Recommend Favorite

Fluvoxamine in the treatment of severe depression

By Zohar Joseph  

Primary Care Psychiatry, Vol. 9, Iss. 4, 2004-12 ,pp. : 115-120

Informa Healthcare

Access to resources Recommend Favorite